A Clinical Study to compare the Efficacy and Safety of Marham-e-DÄ?d with Terbinafine in the Management of QÅ«bÄ? (Ringworm)

Phase 2

• Conditions: Health Condition 1: B354- Tinea corporis

• Registration Number: CTRI/2023/03/051134
• Lead Sponsor: ational Research Institute of Unani Medicine for Skin Disorders

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

a) 1. Circumscribed lesions having any of the following signs and

symptoms on body:

.Presence of pruritus and burning

.Presence of scales_

.Presence of central clearing

.Erythematous papules

b) Participants with positive mycology (KOH positive).

c)| Participants of either sex in age group of 19-60 years.

Exclusion Criteria

a) Co-morbid conditions of the participants

b) Pregnant or Lactating Women

c) Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction

d) Known cases of Immuno-compromised states (HIV/ AIDS, etc.)/Malignancies

Participants not willing to attend treatment schedule regularly

e) History of hypersensitivity to Itraconazole and Terbinafine.

F) Patient having diabetic.

g) Participants using the following medications:

. Systemic antifungal within 15 days of baseline visit.

. Systemic corticosteroids within 15 days of baseline visit.

Study & Design

• Study Type: Interventional
• Study Design: Not specified